APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gonadotropin-releasing Hormone Agonist

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gonadotropin-releasing Hormone Agonist Market Analysis and Forecast 2026-2032

2 January 2026192 pages

Choose your research edition.

Industry ResearchGonadotropin-releasing Hormone Agonist Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Gonadotropin-releasing Hormone Agonist Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Gonadotropin-releasing Hormone Agonist Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gonadotropin-releasing Hormone Agonist Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Gonadotropin-releasing Hormone Agonist Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Gonadotropin-releasing Hormone Agonist market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Gonadotropin-releasing Hormone Agonist is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gonadotropin-releasing Hormone Agonist is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gonadotropin-releasing Hormone Agonist is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gonadotropin-releasing Hormone Agonist is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Gonadotropin-releasing Hormone Agonist include Endo, Ferring, Ipsen, LIVZON, TerSera Therapeutics, AstraZeneca, AbbVie, Sanofi and Takeda, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Gonadotropin-releasing Hormone Agonist, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gonadotropin-releasing Hormone Agonist, also provides the sales of main regions and countries. Of the upcoming market potential for Gonadotropin-releasing Hormone Agonist, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gonadotropin-releasing Hormone Agonist sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gonadotropin-releasing Hormone Agonist market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Gonadotropin-releasing Hormone Agonist sales, projected growth trends, production technology, application and end-user industry.

Gonadotropin-releasing Hormone Agonist Segment by Company

Endo

Ferring

Ipsen

LIVZON

TerSera Therapeutics

AstraZeneca

AbbVie

Sanofi

Takeda

Gonadotropin-releasing Hormone Agonist Segment by Type

Histrelin

Taltirelin

Leuprorelin

Goserelin

Other

Gonadotropin-releasing Hormone Agonist Segment by Application

Hospital

Pharmacy

Other

Gonadotropin-releasing Hormone Agonist Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gonadotropin-releasing Hormone Agonist market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gonadotropin-releasing Hormone Agonist and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gonadotropin-releasing Hormone Agonist.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Gonadotropin-releasing Hormone Agonist in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Gonadotropin-releasing Hormone Agonist manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gonadotropin-releasing Hormone Agonist sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gonadotropin-releasing Hormone Agonist Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Histrelin Major Manufacturers Table 3. Taltirelin Major Manufacturers Table 4. Leuprorelin Major Manufacturers Table 5. Goserelin Major Manufacturers Table 6. Other Major Manufacturers Table 7. Global Gonadotropin-releasing Hormone Agonist Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospital Major Manufacturers Table 9. Pharmacy Major Manufacturers Table 10. Other Major Manufacturers Table 11. Gonadotropin-releasing Hormone Agonist Industry Trends Table 12. Gonadotropin-releasing Hormone Agonist Industry Drivers Table 13. Gonadotropin-releasing Hormone Agonist Industry Opportunities and Challenges Table 14. Gonadotropin-releasing Hormone Agonist Industry Restraints Table 15. Global Gonadotropin-releasing Hormone Agonist Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Gonadotropin-releasing Hormone Agonist Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Gonadotropin-releasing Hormone Agonist Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Region (2021-2026) Table 19. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Region (2027-2032) Table 20. Global Gonadotropin-releasing Hormone Agonist Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Gonadotropin-releasing Hormone Agonist Sales by Region (2021-2026) & (K Units) Table 22. Global Gonadotropin-releasing Hormone Agonist Sales by Region (2027-2032) & (K Units) Table 23. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Region (2021-2026) Table 24. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Region (2027-2032) Table 25. Global Gonadotropin-releasing Hormone Agonist Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Gonadotropin-releasing Hormone Agonist Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Manufacturers (2021-2026) Table 29. Global Gonadotropin-releasing Hormone Agonist Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Gonadotropin-releasing Hormone Agonist Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Gonadotropin-releasing Hormone Agonist Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Gonadotropin-releasing Hormone Agonist Manufacturers, Product Type & Application Table 33. Global Gonadotropin-releasing Hormone Agonist Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Gonadotropin-releasing Hormone Agonist by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Gonadotropin-releasing Hormone Agonist Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Gonadotropin-releasing Hormone Agonist Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Gonadotropin-releasing Hormone Agonist Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Type (2021-2026) Table 40. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Type (2027-2032) Table 41. Global Gonadotropin-releasing Hormone Agonist Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Gonadotropin-releasing Hormone Agonist Sales by Type (2021-2026) & (K Units) Table 43. Global Gonadotropin-releasing Hormone Agonist Sales by Type (2027-2032) & (K Units) Table 44. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Type (2021-2026) Table 45. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Type (2027-2032) Table 46. Global Gonadotropin-releasing Hormone Agonist Price by Type (2021-2026) & (US$/Unit) Table 47. Global Gonadotropin-releasing Hormone Agonist Price by Type (2027-2032) & (US$/Unit) Table 48. Global Gonadotropin-releasing Hormone Agonist Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Gonadotropin-releasing Hormone Agonist Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Gonadotropin-releasing Hormone Agonist Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Application (2021-2026) Table 52. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Application (2027-2032) Table 53. Global Gonadotropin-releasing Hormone Agonist Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Gonadotropin-releasing Hormone Agonist Sales by Application (2021-2026) & (K Units) Table 55. Global Gonadotropin-releasing Hormone Agonist Sales by Application (2027-2032) & (K Units) Table 56. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Application (2021-2026) Table 57. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Application (2027-2032) Table 58. Global Gonadotropin-releasing Hormone Agonist Price by Application (2021-2026) & (US$/Unit) Table 59. Global Gonadotropin-releasing Hormone Agonist Price by Application (2027-2032) & (US$/Unit) Table 60. Endo Company Information Table 61. Endo Business Overview Table 62. Endo Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Endo Gonadotropin-releasing Hormone Agonist Product Portfolio Table 64. Endo Recent Development Table 65. Ferring Company Information Table 66. Ferring Business Overview Table 67. Ferring Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Ferring Gonadotropin-releasing Hormone Agonist Product Portfolio Table 69. Ferring Recent Development Table 70. Ipsen Company Information Table 71. Ipsen Business Overview Table 72. Ipsen Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Ipsen Gonadotropin-releasing Hormone Agonist Product Portfolio Table 74. Ipsen Recent Development Table 75. LIVZON Company Information Table 76. LIVZON Business Overview Table 77. LIVZON Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. LIVZON Gonadotropin-releasing Hormone Agonist Product Portfolio Table 79. LIVZON Recent Development Table 80. TerSera Therapeutics Company Information Table 81. TerSera Therapeutics Business Overview Table 82. TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Product Portfolio Table 84. TerSera Therapeutics Recent Development Table 85. AstraZeneca Company Information Table 86. AstraZeneca Business Overview Table 87. AstraZeneca Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. AstraZeneca Gonadotropin-releasing Hormone Agonist Product Portfolio Table 89. AstraZeneca Recent Development Table 90. AbbVie Company Information Table 91. AbbVie Business Overview Table 92. AbbVie Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. AbbVie Gonadotropin-releasing Hormone Agonist Product Portfolio Table 94. AbbVie Recent Development Table 95. Sanofi Company Information Table 96. Sanofi Business Overview Table 97. Sanofi Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Sanofi Gonadotropin-releasing Hormone Agonist Product Portfolio Table 99. Sanofi Recent Development Table 100. Takeda Company Information Table 101. Takeda Business Overview Table 102. Takeda Gonadotropin-releasing Hormone Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Takeda Gonadotropin-releasing Hormone Agonist Product Portfolio Table 104. Takeda Recent Development Table 105. North America Gonadotropin-releasing Hormone Agonist Revenue by Type (2021-2026) & (US$ Million) Table 106. North America Gonadotropin-releasing Hormone Agonist Revenue by Type (2027-2032) & (US$ Million) Table 107. North America Gonadotropin-releasing Hormone Agonist Sales by Type (2021-2026) & (K Units) Table 108. North America Gonadotropin-releasing Hormone Agonist Sales by Type (2027-2032) & (K Units) Table 109. North America Gonadotropin-releasing Hormone Agonist Sales Price by Type (2021-2026) & (US$/Unit) Table 110. North America Gonadotropin-releasing Hormone Agonist Sales Price by Type (2027-2032) & (US$/Unit) Table 111. North America Gonadotropin-releasing Hormone Agonist Revenue by Application (2021-2026) & (US$ Million) Table 112. North America Gonadotropin-releasing Hormone Agonist Revenue by Application (2027-2032) & (US$ Million) Table 113. North America Gonadotropin-releasing Hormone Agonist Sales by Application (2021-2026) & (K Units) Table 114. North America Gonadotropin-releasing Hormone Agonist Sales by Application (2027-2032) & (K Units) Table 115. North America Gonadotropin-releasing Hormone Agonist Sales Price by Application (2021-2026) & (US$/Unit) Table 116. North America Gonadotropin-releasing Hormone Agonist Sales Price by Application (2027-2032) & (US$/Unit) Table 117. North America Gonadotropin-releasing Hormone Agonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. North America Gonadotropin-releasing Hormone Agonist Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 119. North America Gonadotropin-releasing Hormone Agonist Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 120. North America Gonadotropin-releasing Hormone Agonist Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 121. North America Gonadotropin-releasing Hormone Agonist Sales by Country (2021-2026) & (K Units) Table 122. North America Gonadotropin-releasing Hormone Agonist Sales by Country (2027-2032) & (K Units) Table 123. North America Gonadotropin-releasing Hormone Agonist Sales Price by Country (2021-2026) & (US$/Unit) Table 124. North America Gonadotropin-releasing Hormone Agonist Sales Price by Country (2027-2032) & (US$/Unit) Table 125. United States Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 126. Canada Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 127. Europe Gonadotropin-releasing Hormone Agonist Revenue by Type (2021-2026) & (US$ Million) Table 128. Europe Gonadotropin-releasing Hormone Agonist Revenue by Type (2027-2032) & (US$ Million) Table 129. Europe Gonadotropin-releasing Hormone Agonist Sales by Type (2021-2026) & (K Units) Table 130. Europe Gonadotropin-releasing Hormone Agonist Sales by Type (2027-2032) & (K Units) Table 131. Europe Gonadotropin-releasing Hormone Agonist Sales Price by Type (2021-2026) & (US$/Unit) Table 132. Europe Gonadotropin-releasing Hormone Agonist Sales Price by Type (2027-2032) & (US$/Unit) Table 133. Europe Gonadotropin-releasing Hormone Agonist Revenue by Application (2021-2026) & (US$ Million) Table 134. Europe Gonadotropin-releasing Hormone Agonist Revenue by Application (2027-2032) & (US$ Million) Table 135. Europe Gonadotropin-releasing Hormone Agonist Sales by Application (2021-2026) & (K Units) Table 136. Europe Gonadotropin-releasing Hormone Agonist Sales by Application (2027-2032) & (K Units) Table 137. Europe Gonadotropin-releasing Hormone Agonist Sales Price by Application (2021-2026) & (US$/Unit) Table 138. Europe Gonadotropin-releasing Hormone Agonist Sales Price by Application (2027-2032) & (US$/Unit) Table 139. Europe Gonadotropin-releasing Hormone Agonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Europe Gonadotropin-releasing Hormone Agonist Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 141. Europe Gonadotropin-releasing Hormone Agonist Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 142. Europe Gonadotropin-releasing Hormone Agonist Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 143. Europe Gonadotropin-releasing Hormone Agonist Sales by Country (2021-2026) & (K Units) Table 144. Europe Gonadotropin-releasing Hormone Agonist Sales by Country (2027-2032) & (K Units) Table 145. Europe Gonadotropin-releasing Hormone Agonist Sales Price by Country (2021-2026) & (US$/Unit) Table 146. Europe Gonadotropin-releasing Hormone Agonist Sales Price by Country (2027-2032) & (US$/Unit) Table 147. Germany Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 148. France Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 149. U.K. Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 150. Italy Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 151. Netherlands Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 152. China Gonadotropin-releasing Hormone Agonist Revenue by Type (2021-2026) & (US$ Million) Table 153. China Gonadotropin-releasing Hormone Agonist Revenue by Type (2027-2032) & (US$ Million) Table 154. China Gonadotropin-releasing Hormone Agonist Sales by Type (2021-2026) & (K Units) Table 155. China Gonadotropin-releasing Hormone Agonist Sales by Type (2027-2032) & (K Units) Table 156. China Gonadotropin-releasing Hormone Agonist Sales Price by Type (2021-2026) & (US$/Unit) Table 157. China Gonadotropin-releasing Hormone Agonist Sales Price by Type (2027-2032) & (US$/Unit) Table 158. China Gonadotropin-releasing Hormone Agonist Revenue by Application (2021-2026) & (US$ Million) Table 159. China Gonadotropin-releasing Hormone Agonist Revenue by Application (2027-2032) & (US$ Million) Table 160. China Gonadotropin-releasing Hormone Agonist Sales by Application (2021-2026) & (K Units) Table 161. China Gonadotropin-releasing Hormone Agonist Sales by Application (2027-2032) & (K Units) Table 162. China Gonadotropin-releasing Hormone Agonist Sales Price by Application (2021-2026) & (US$/Unit) Table 163. China Gonadotropin-releasing Hormone Agonist Sales Price by Application (2027-2032) & (US$/Unit) Table 164. Asia Gonadotropin-releasing Hormone Agonist Revenue by Type (2021-2026) & (US$ Million) Table 165. Asia Gonadotropin-releasing Hormone Agonist Revenue by Type (2027-2032) & (US$ Million) Table 166. Asia Gonadotropin-releasing Hormone Agonist Sales by Type (2021-2026) & (K Units) Table 167. Asia Gonadotropin-releasing Hormone Agonist Sales by Type (2027-2032) & (K Units) Table 168. Asia Gonadotropin-releasing Hormone Agonist Sales Price by Type (2021-2026) & (US$/Unit) Table 169. Asia Gonadotropin-releasing Hormone Agonist Sales Price by Type (2027-2032) & (US$/Unit) Table 170. Asia Gonadotropin-releasing Hormone Agonist Revenue by Application (2021-2026) & (US$ Million) Table 171. Asia Gonadotropin-releasing Hormone Agonist Revenue by Application (2027-2032) & (US$ Million) Table 172. Asia Gonadotropin-releasing Hormone Agonist Sales by Application (2021-2026) & (K Units) Table 173. Asia Gonadotropin-releasing Hormone Agonist Sales by Application (2027-2032) & (K Units) Table 174. Asia Gonadotropin-releasing Hormone Agonist Sales Price by Application (2021-2026) & (US$/Unit) Table 175. Asia Gonadotropin-releasing Hormone Agonist Sales Price by Application (2027-2032) & (US$/Unit) Table 176. Asia Gonadotropin-releasing Hormone Agonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. Asia Gonadotropin-releasing Hormone Agonist Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. Asia Gonadotropin-releasing Hormone Agonist Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. Asia Gonadotropin-releasing Hormone Agonist Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 180. Asia Gonadotropin-releasing Hormone Agonist Sales by Country (2021-2026) & (K Units) Table 181. Asia Gonadotropin-releasing Hormone Agonist Sales by Country (2027-2032) & (K Units) Table 182. Asia Gonadotropin-releasing Hormone Agonist Sales Price by Country (2021-2026) & (US$/Unit) Table 183. Asia Gonadotropin-releasing Hormone Agonist Sales Price by Country (2027-2032) & (US$/Unit) Table 184. Japan Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 185. South Korea Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 186. India Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 187. Australia Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 188. China Taiwan Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 189. Southeast Asia Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 190. SAMEA Gonadotropin-releasing Hormone Agonist Revenue by Type (2021-2026) & (US$ Million) Table 191. SAMEA Gonadotropin-releasing Hormone Agonist Revenue by Type (2027-2032) & (US$ Million) Table 192. SAMEA Gonadotropin-releasing Hormone Agonist Sales by Type (2021-2026) & (K Units) Table 193. SAMEA Gonadotropin-releasing Hormone Agonist Sales by Type (2027-2032) & (K Units) Table 194. SAMEA Gonadotropin-releasing Hormone Agonist Sales Price by Type (2021-2026) & (US$/Unit) Table 195. SAMEA Gonadotropin-releasing Hormone Agonist Sales Price by Type (2027-2032) & (US$/Unit) Table 196. SAMEA Gonadotropin-releasing Hormone Agonist Revenue by Application (2021-2026) & (US$ Million) Table 197. SAMEA Gonadotropin-releasing Hormone Agonist Revenue by Application (2027-2032) & (US$ Million) Table 198. SAMEA Gonadotropin-releasing Hormone Agonist Sales by Application (2021-2026) & (K Units) Table 199. SAMEA Gonadotropin-releasing Hormone Agonist Sales by Application (2027-2032) & (K Units) Table 200. SAMEA Gonadotropin-releasing Hormone Agonist Sales Price by Application (2021-2026) & (US$/Unit) Table 201. SAMEA Gonadotropin-releasing Hormone Agonist Sales Price by Application (2027-2032) & (US$/Unit) Table 202. SAMEA Gonadotropin-releasing Hormone Agonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 203. SAMEA Gonadotropin-releasing Hormone Agonist Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 204. SAMEA Gonadotropin-releasing Hormone Agonist Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 205. SAMEA Gonadotropin-releasing Hormone Agonist Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 206. SAMEA Gonadotropin-releasing Hormone Agonist Sales by Country (2021-2026) & (K Units) Table 207. SAMEA Gonadotropin-releasing Hormone Agonist Sales by Country (2027-2032) & (K Units) Table 208. SAMEA Gonadotropin-releasing Hormone Agonist Sales Price by Country (2021-2026) & (US$/Unit) Table 209. SAMEA Gonadotropin-releasing Hormone Agonist Sales Price by Country (2027-2032) & (US$/Unit) Table 210. Brazil Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 211. Argentina Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 212. Chile Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 213. Colombia Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 214. Peru Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 215. Saudi Arabia Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 216. Israel Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 217. UAE Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 218. Turkey Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 219. Iran Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 220. Egypt Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Gonadotropin-releasing Hormone Agonist Distributors List Table 224. Gonadotropin-releasing Hormone Agonist Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Gonadotropin-releasing Hormone Agonist Image Figure 2. Global Gonadotropin-releasing Hormone Agonist Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gonadotropin-releasing Hormone Agonist Market Size Share 2021 VS 2025 VS 2032 Figure 4. Histrelin Image Figure 5. Taltirelin Image Figure 6. Leuprorelin Image Figure 7. Goserelin Image Figure 8. Other Image Figure 9. Global Gonadotropin-releasing Hormone Agonist Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Gonadotropin-releasing Hormone Agonist Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospital Image Figure 12. Pharmacy Image Figure 13. Other Image Figure 14. Global Gonadotropin-releasing Hormone Agonist Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Gonadotropin-releasing Hormone Agonist Revenue (2021-2032) & (US$ Million) Figure 16. Global Gonadotropin-releasing Hormone Agonist Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Region (2021-2032) Figure 19. Global Gonadotropin-releasing Hormone Agonist Sales (2021-2032) & (K Units) Figure 20. Global Gonadotropin-releasing Hormone Agonist Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Gonadotropin-releasing Hormone Agonist Sales YoY (2021-2032) & (K Units) Figure 23. Europe Gonadotropin-releasing Hormone Agonist Sales YoY (2021-2032) & (K Units) Figure 24. China Gonadotropin-releasing Hormone Agonist Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Gonadotropin-releasing Hormone Agonist Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Gonadotropin-releasing Hormone Agonist Sales YoY (2021-2032) & (K Units) Figure 27. Global Gonadotropin-releasing Hormone Agonist Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Gonadotropin-releasing Hormone Agonist Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Gonadotropin-releasing Hormone Agonist Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Type (2021-2032) Figure 33. Global Gonadotropin-releasing Hormone Agonist Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Type (2021-2032) Figure 36. Global Gonadotropin-releasing Hormone Agonist Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Application (2021-2032) Figure 39. Global Gonadotropin-releasing Hormone Agonist Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Application (2021-2032) Figure 42. North America Gonadotropin-releasing Hormone Agonist Revenue Share by Type (2021-2032) Figure 43. North America Gonadotropin-releasing Hormone Agonist Sales Share by Type (2021-2032) Figure 44. North America Gonadotropin-releasing Hormone Agonist Revenue Share by Application (2021-2032) Figure 45. North America Gonadotropin-releasing Hormone Agonist Sales Share by Application (2021-2032) Figure 46. North America Gonadotropin-releasing Hormone Agonist Revenue Share by Country (2021-2032) Figure 47. North America Gonadotropin-releasing Hormone Agonist Sales Share by Country (2021-2032) Figure 48. Europe Gonadotropin-releasing Hormone Agonist Revenue Share by Type (2021-2032) Figure 49. Europe Gonadotropin-releasing Hormone Agonist Sales Share by Type (2021-2032) Figure 50. Europe Gonadotropin-releasing Hormone Agonist Revenue Share by Application (2021-2032) Figure 51. Europe Gonadotropin-releasing Hormone Agonist Sales Share by Application (2021-2032) Figure 52. Europe Gonadotropin-releasing Hormone Agonist Revenue Share by Country (2021-2032) Figure 53. Europe Gonadotropin-releasing Hormone Agonist Sales Share by Country (2021-2032) Figure 54. China Gonadotropin-releasing Hormone Agonist Revenue Share by Type (2021-2032) Figure 55. China Gonadotropin-releasing Hormone Agonist Sales Share by Type (2021-2032) Figure 56. China Gonadotropin-releasing Hormone Agonist Revenue Share by Application (2021-2032) Figure 57. China Gonadotropin-releasing Hormone Agonist Sales Share by Application (2021-2032) Figure 58. Asia Gonadotropin-releasing Hormone Agonist Revenue Share by Type (2021-2032) Figure 59. Asia Gonadotropin-releasing Hormone Agonist Sales Share by Type (2021-2032) Figure 60. Asia Gonadotropin-releasing Hormone Agonist Revenue Share by Application (2021-2032) Figure 61. Asia Gonadotropin-releasing Hormone Agonist Sales Share by Application (2021-2032) Figure 62. Asia Gonadotropin-releasing Hormone Agonist Revenue Share by Country (2021-2032) Figure 63. Asia Gonadotropin-releasing Hormone Agonist Sales Share by Country (2021-2032) Figure 64. SAMEA Gonadotropin-releasing Hormone Agonist Revenue Share by Type (2021-2032) Figure 65. SAMEA Gonadotropin-releasing Hormone Agonist Sales Share by Type (2021-2032) Figure 66. SAMEA Gonadotropin-releasing Hormone Agonist Revenue Share by Application (2021-2032) Figure 67. SAMEA Gonadotropin-releasing Hormone Agonist Sales Share by Application (2021-2032) Figure 68. SAMEA Gonadotropin-releasing Hormone Agonist Revenue Share by Country (2021-2032) Figure 69. SAMEA Gonadotropin-releasing Hormone Agonist Sales Share by Country (2021-2032) Figure 70. Gonadotropin-releasing Hormone Agonist Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Gonadotropin-releasing Hormone Agonist Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Histrelin
  • Taltirelin
  • Leuprorelin
  • Goserelin
  • Other
Applications
  • Hospital
  • Pharmacy
  • Other
Companies covered
  • Endo
  • Ferring
  • Ipsen
  • LIVZON
  • TerSera Therapeutics
  • AstraZeneca
  • AbbVie
  • Sanofi
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gonadotropin-releasing Hormone Agonist Market by Type
  3. 1.2.1 Global Gonadotropin-releasing Hormone Agonist Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Histrelin
  5. 1.2.3 Taltirelin
  6. 1.2.4 Leuprorelin
  7. 1.2.5 Goserelin
  8. 1.2.6 Other
  9. 1.3 Gonadotropin-releasing Hormone Agonist Market by Application
  10. 1.3.1 Global Gonadotropin-releasing Hormone Agonist Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital
  12. 1.3.3 Pharmacy
  13. 1.3.4 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Gonadotropin-releasing Hormone Agonist Market Dynamics
  1. 2.1 Gonadotropin-releasing Hormone Agonist Industry Trends
  2. 2.2 Gonadotropin-releasing Hormone Agonist Industry Drivers
  3. 2.3 Gonadotropin-releasing Hormone Agonist Industry Opportunities and Challenges
  4. 2.4 Gonadotropin-releasing Hormone Agonist Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Gonadotropin-releasing Hormone Agonist Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Gonadotropin-releasing Hormone Agonist Revenue by Region
  3. 3.2.1 Global Gonadotropin-releasing Hormone Agonist Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gonadotropin-releasing Hormone Agonist Revenue by Region (2021-2026)
  5. 3.2.3 Global Gonadotropin-releasing Hormone Agonist Revenue by Region (2027-2032)
  6. 3.2.4 Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Gonadotropin-releasing Hormone Agonist Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Gonadotropin-releasing Hormone Agonist Sales by Region
  9. 3.4.1 Global Gonadotropin-releasing Hormone Agonist Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Gonadotropin-releasing Hormone Agonist Sales by Region (2021-2026)
  11. 3.4.3 Global Gonadotropin-releasing Hormone Agonist Sales by Region (2027-2032)
  12. 3.4.4 Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Gonadotropin-releasing Hormone Agonist Revenue by Manufacturers
  2. 4.1.1 Global Gonadotropin-releasing Hormone Agonist Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Gonadotropin-releasing Hormone Agonist Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gonadotropin-releasing Hormone Agonist Sales by Manufacturers
  6. 4.2.1 Global Gonadotropin-releasing Hormone Agonist Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Gonadotropin-releasing Hormone Agonist Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Gonadotropin-releasing Hormone Agonist Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Gonadotropin-releasing Hormone Agonist Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Gonadotropin-releasing Hormone Agonist Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Gonadotropin-releasing Hormone Agonist Manufacturers, Product Type & Application
  13. 4.7 Global Gonadotropin-releasing Hormone Agonist Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Gonadotropin-releasing Hormone Agonist Market CR5 and HHI
  16. 4.8.2 2025 Gonadotropin-releasing Hormone Agonist Tier 1, Tier 2, and Tier 3
5 Gonadotropin-releasing Hormone Agonist Market by Type
  1. 5.1 Global Gonadotropin-releasing Hormone Agonist Revenue by Type
  2. 5.1.1 Global Gonadotropin-releasing Hormone Agonist Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Gonadotropin-releasing Hormone Agonist Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Gonadotropin-releasing Hormone Agonist Sales by Type
  6. 5.2.1 Global Gonadotropin-releasing Hormone Agonist Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gonadotropin-releasing Hormone Agonist Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Type (2021-2032)
  9. 5.3 Global Gonadotropin-releasing Hormone Agonist Price by Type
6 Gonadotropin-releasing Hormone Agonist Market by Application
  1. 6.1 Global Gonadotropin-releasing Hormone Agonist Revenue by Application
  2. 6.1.1 Global Gonadotropin-releasing Hormone Agonist Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Gonadotropin-releasing Hormone Agonist Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Gonadotropin-releasing Hormone Agonist Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Gonadotropin-releasing Hormone Agonist Sales by Application
  6. 6.2.1 Global Gonadotropin-releasing Hormone Agonist Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Gonadotropin-releasing Hormone Agonist Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Gonadotropin-releasing Hormone Agonist Sales Market Share by Application (2021-2032)
  9. 6.3 Global Gonadotropin-releasing Hormone Agonist Price by Application
7 Company Profiles
  1. 7.1 Endo
  2. 7.1.1 Endo Company Information
  3. 7.1.2 Endo Business Overview
  4. 7.1.3 Endo Gonadotropin-releasing Hormone Agonist Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Endo Gonadotropin-releasing Hormone Agonist Product Portfolio
  6. 7.1.5 Endo Recent Developments
  7. 7.2 Ferring
  8. 7.2.1 Ferring Company Information
  9. 7.2.2 Ferring Business Overview
  10. 7.2.3 Ferring Gonadotropin-releasing Hormone Agonist Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Ferring Gonadotropin-releasing Hormone Agonist Product Portfolio
  12. 7.2.5 Ferring Recent Developments
  13. 7.3 Ipsen
  14. 7.3.1 Ipsen Company Information
  15. 7.3.2 Ipsen Business Overview
  16. 7.3.3 Ipsen Gonadotropin-releasing Hormone Agonist Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Ipsen Gonadotropin-releasing Hormone Agonist Product Portfolio
  18. 7.3.5 Ipsen Recent Developments
  19. 7.4 LIVZON
  20. 7.4.1 LIVZON Company Information
  21. 7.4.2 LIVZON Business Overview
  22. 7.4.3 LIVZON Gonadotropin-releasing Hormone Agonist Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 LIVZON Gonadotropin-releasing Hormone Agonist Product Portfolio
  24. 7.4.5 LIVZON Recent Developments
  25. 7.5 TerSera Therapeutics
  26. 7.5.1 TerSera Therapeutics Company Information
  27. 7.5.2 TerSera Therapeutics Business Overview
  28. 7.5.3 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Product Portfolio
  30. 7.5.5 TerSera Therapeutics Recent Developments
  31. 7.6 AstraZeneca
  32. 7.6.1 AstraZeneca Company Information
  33. 7.6.2 AstraZeneca Business Overview
  34. 7.6.3 AstraZeneca Gonadotropin-releasing Hormone Agonist Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 AstraZeneca Gonadotropin-releasing Hormone Agonist Product Portfolio
  36. 7.6.5 AstraZeneca Recent Developments
  37. 7.7 AbbVie
  38. 7.7.1 AbbVie Company Information
  39. 7.7.2 AbbVie Business Overview
  40. 7.7.3 AbbVie Gonadotropin-releasing Hormone Agonist Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 AbbVie Gonadotropin-releasing Hormone Agonist Product Portfolio
  42. 7.7.5 AbbVie Recent Developments
  43. 7.8 Sanofi
  44. 7.8.1 Sanofi Company Information
  45. 7.8.2 Sanofi Business Overview
  46. 7.8.3 Sanofi Gonadotropin-releasing Hormone Agonist Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sanofi Gonadotropin-releasing Hormone Agonist Product Portfolio
  48. 7.8.5 Sanofi Recent Developments
  49. 7.9 Takeda
  50. 7.9.1 Takeda Company Information
  51. 7.9.2 Takeda Business Overview
  52. 7.9.3 Takeda Gonadotropin-releasing Hormone Agonist Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Takeda Gonadotropin-releasing Hormone Agonist Product Portfolio
  54. 7.9.5 Takeda Recent Developments
8 North America
  1. 8.1 North America Gonadotropin-releasing Hormone Agonist Market Size by Type
  2. 8.1.1 North America Gonadotropin-releasing Hormone Agonist Revenue by Type (2021-2032)
  3. 8.1.2 North America Gonadotropin-releasing Hormone Agonist Sales by Type (2021-2032)
  4. 8.1.3 North America Gonadotropin-releasing Hormone Agonist Price by Type (2021-2032)
  5. 8.2 North America Gonadotropin-releasing Hormone Agonist Market Size by Application
  6. 8.2.1 North America Gonadotropin-releasing Hormone Agonist Revenue by Application (2021-2032)
  7. 8.2.2 North America Gonadotropin-releasing Hormone Agonist Sales by Application (2021-2032)
  8. 8.2.3 North America Gonadotropin-releasing Hormone Agonist Price by Application (2021-2032)
  9. 8.3 North America Gonadotropin-releasing Hormone Agonist Market Size by Country
  10. 8.3.1 North America Gonadotropin-releasing Hormone Agonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Gonadotropin-releasing Hormone Agonist Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Gonadotropin-releasing Hormone Agonist Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Gonadotropin-releasing Hormone Agonist Market Size by Type
  2. 9.1.1 Europe Gonadotropin-releasing Hormone Agonist Revenue by Type (2021-2032)
  3. 9.1.2 Europe Gonadotropin-releasing Hormone Agonist Sales by Type (2021-2032)
  4. 9.1.3 Europe Gonadotropin-releasing Hormone Agonist Price by Type (2021-2032)
  5. 9.2 Europe Gonadotropin-releasing Hormone Agonist Market Size by Application
  6. 9.2.1 Europe Gonadotropin-releasing Hormone Agonist Revenue by Application (2021-2032)
  7. 9.2.2 Europe Gonadotropin-releasing Hormone Agonist Sales by Application (2021-2032)
  8. 9.2.3 Europe Gonadotropin-releasing Hormone Agonist Price by Application (2021-2032)
  9. 9.3 Europe Gonadotropin-releasing Hormone Agonist Market Size by Country
  10. 9.3.1 Europe Gonadotropin-releasing Hormone Agonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Gonadotropin-releasing Hormone Agonist Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Gonadotropin-releasing Hormone Agonist Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Gonadotropin-releasing Hormone Agonist Market Size by Type
  2. 10.1.1 China Gonadotropin-releasing Hormone Agonist Revenue by Type (2021-2032)
  3. 10.1.2 China Gonadotropin-releasing Hormone Agonist Sales by Type (2021-2032)
  4. 10.1.3 China Gonadotropin-releasing Hormone Agonist Price by Type (2021-2032)
  5. 10.2 China Gonadotropin-releasing Hormone Agonist Market Size by Application
  6. 10.2.1 China Gonadotropin-releasing Hormone Agonist Revenue by Application (2021-2032)
  7. 10.2.2 China Gonadotropin-releasing Hormone Agonist Sales by Application (2021-2032)
  8. 10.2.3 China Gonadotropin-releasing Hormone Agonist Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gonadotropin-releasing Hormone Agonist Market Size by Type
  2. 11.1.1 Asia Gonadotropin-releasing Hormone Agonist Revenue by Type (2021-2032)
  3. 11.1.2 Asia Gonadotropin-releasing Hormone Agonist Sales by Type (2021-2032)
  4. 11.1.3 Asia Gonadotropin-releasing Hormone Agonist Price by Type (2021-2032)
  5. 11.2 Asia Gonadotropin-releasing Hormone Agonist Market Size by Application
  6. 11.2.1 Asia Gonadotropin-releasing Hormone Agonist Revenue by Application (2021-2032)
  7. 11.2.2 Asia Gonadotropin-releasing Hormone Agonist Sales by Application (2021-2032)
  8. 11.2.3 Asia Gonadotropin-releasing Hormone Agonist Price by Application (2021-2032)
  9. 11.3 Asia Gonadotropin-releasing Hormone Agonist Market Size by Country
  10. 11.3.1 Asia Gonadotropin-releasing Hormone Agonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Gonadotropin-releasing Hormone Agonist Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Gonadotropin-releasing Hormone Agonist Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gonadotropin-releasing Hormone Agonist Market Size by Type
  2. 12.1.1 SAMEA Gonadotropin-releasing Hormone Agonist Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Gonadotropin-releasing Hormone Agonist Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Gonadotropin-releasing Hormone Agonist Price by Type (2021-2032)
  5. 12.2 SAMEA Gonadotropin-releasing Hormone Agonist Market Size by Application
  6. 12.2.1 SAMEA Gonadotropin-releasing Hormone Agonist Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Gonadotropin-releasing Hormone Agonist Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Gonadotropin-releasing Hormone Agonist Price by Application (2021-2032)
  9. 12.3 SAMEA Gonadotropin-releasing Hormone Agonist Market Size by Country
  10. 12.3.1 SAMEA Gonadotropin-releasing Hormone Agonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Gonadotropin-releasing Hormone Agonist Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Gonadotropin-releasing Hormone Agonist Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Gonadotropin-releasing Hormone Agonist Value Chain Analysis
  2. 13.1.1 Gonadotropin-releasing Hormone Agonist Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Gonadotropin-releasing Hormone Agonist Production Mode & Process
  6. 13.2 Gonadotropin-releasing Hormone Agonist Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Gonadotropin-releasing Hormone Agonist Distributors
  9. 13.2.3 Gonadotropin-releasing Hormone Agonist Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst